Sachs Associates would like to say we enjoyed hosting you at our 9th Annual Neuroscience Innovation Forum (#Sachs_NIF). We would like to thank those who joined us in-person in San Francisco and those who participated virtually last week. A special thank you goes to the excellent lineup of sponsors, chairs, panellists, and presenters who made such a broad and interesting programme possible. Once again, the forum demonstrated its strong value to the neuroscience community, with over 440 participants from 22 countries registered and a record number of in-person attendees. To view photos from the event, please navigate to the 'PHOTOS’ tab. To watch a session on-demand, please navigate to the 'RECORDINGS' tab and select the panel or session you want to view. To view showcases, please click on the 'PRESENTERS' tab. Each company will have a showcase button, which will allow you to view their presentation. The Online Meeting System and Event Portal will be available for review, messaging people, and exchanging contacts with people you did not have a chance to meet until the 11th of February 2026. We look forward to welcoming you again to our future events!
CONTRIBUTING SPONSOR:

Presenting Companies Included:


Mosaica Medicines, Inc.


Confirmed Keynote Speakers Included:
BF
Brian Fiske
Chief Scientific Officer, The Michael J. Fox Foundation for Parkinson's Research
HT
Harry Tracy
President, NI Research Inc.
JJ
Jonathan Javitt
CEO, NRx Pharmaceuticals, Inc.
Speakers and Chairs Included:
BL
Bruce Leuchter
President & CEO, Neurvati Neurosciences, Inc.
CL
Carla Lema Tomé
Executive Director Business Development, Head of US BD, Otsuka Pharmaceutical Co., Ltd.
DL
Daniel Lee
Partner, PJT Partners

Diana Saraceni
Co-Founder & General Partner, Panakès Partners SGR SpA
GJ
Ginger Johnson
SVP, Neuroscience Lead, Lumanity
Jay Olson
Managing Director & Senior Analyst, Oppenheimer & Co. Inc.
JC
Jeffrey Cohen
Director of Research, Ladenburg Thalmann & Co. Inc.
Joel Sandler
Associate Partner, Ipsos Healthcare Advisory Service
ML
Manuel López-Figueroa
Scientific Liaison, Pritzker Neuropsychiatric Disorders Research Consortium
MG
Murali Gopalakrishnan
Global Head, Neuroscience Search & Evaluation, Corporate Strategy Office, AbbVie, Inc.
Steve Dickman
CEO, CBT Advisors
SK
Sumant Kulkarni
Managing Director, Biotechnology Equity Research, Canaccord Genuity LLC
TS
Thomas Shrader
Managing Director & Healthcare Analyst, BTIG, LLC
AG
Alexander Gebauer
Co-Founder & Executive Chairman, Galimedix Therapeutics, Inc.
AE
Amit Etkin
Founder & CEO, Alto Neuroscience Inc.
AC
Andrea Chicca
Co-Founder & CEO, Synendos Therapeutics AG
AC
Anthony Caggiano
Chief Medical Officer, Cognition Therapeutics, Inc.
Ad
Arno de Wilde
Managing Director, EQT Life Sciences
Carlos Buesa
Founder & CEO, Oryzon Genomics, S.A.
CS
Cassandra Snipes
Senior Director Scientific Innovations, Click Therapeutics, Inc.
CB
Celine Bouquet
Neuroscience, Ophthalmology & Rare Diseases Pharma Partnering Site Head Basel, F. Hoffmann-La Roche Ltd.
CW
Chris Witowski
Co-Founder & CEO, Psilera Inc.
CP
Christos Papadimitriou
Co-Founder & CEO, Tessara Therapeutics Pty Ltd.
DS
Derek Small
Founding CEO, Luson Bioventures
ES
Eric Snyder
Partner, Novo Holdings US Inc.
GS
Gaia Skibinski
Director of Discovery & Translational Research, The Michael J. Fox Foundation for Parkinson's Research
GM
Gene Mack
President & CEO, Gain Therapeutics, Inc.
GM
Greg Mayes
President & CEO, Reunion Neuroscience, Inc.
GM
Gregor Macdonald
VP, Head of BD & Licensing, Search & Assessment, H. Lundbeck A/S

Hugh Nuthall
Executive Director, Search & Evaluation Neuroscience, Eli Lilly and Company
JC
James Cavuoto
Editor & Publisher, Neurotech Reports
JB
Jonathan Behr
Partner, Dementia Discovery Fund, an SV Health Investors, LLC Fund
JT
Joseph Tucker
CEO, Enveric BioSciences, Inc.
JH
Justin Hanka
Co-Founder & CEO, MindBio Therapeutics
KN
Kabir Nath
CEO, Compass Pathways
Karen Harris
CFO & Head of Mission Related Investments, Alzheimer's Drug Discovery Foundation
KM
Ken Mariash
CEO, Sinaptica Therapeutics, Inc.
LR
Laura Ripin
VP, Head BD&L Transactions Neuroscience, Novartis Pharma AG
Lynn Durham
Founder & CEO, STALICLA SA
ML
Mankit Law
Senior Director, BD, Search & Evaluation, GSK
MR
Mark Rus
President & CEO, Delix Therapeutics, Inc.
NM
Nick Manusos
CEO, Kenai Therapeutics
PD
Paolo Di Giorgio
Managing Director & CEO, Angelini Ventures S.p.A.
RK
Rotem Kopel
CEO, ABILITY Neurotech
SM
Samantha Murphy
Vice President, Corporate Development, Aspen Neuroscience, Inc.
SK
Sarah Kleinpeter
SVP, Head of Alzheimer's & Dementia Franchise, Biogen
SL
Seth Lederman
Chairman & CEO, Tonix Pharmaceuticals Holding Corp.
SB
Spring Behrouz
CEO, Vincere Biosciences Inc.
SR
Srinivas Rao
Co-Founder & CEO, AtaiBeckley
SK
Stefan König
CEO, Merz Therapeutics GmbH
Yury Kukushkin
Investment Partner, Hevolution